Main menu


The "FDA" issues its decision regarding approval of the Corona vaccine from Johnson tomorrow

The British newspaper "Daily Mail" revealed that the US Food and Drug Administration "FDA" will take a decision about Johnson's vaccine for Coronavirus, which is characterized by only one dose, on Friday, and the FDA said that one dose of Johnson's vaccine protects against infection with the Coronavirus .

Officials found that the vaccine was 68% effective against the alternative in Brazil, and 64% effective against the South African alternative, and independent agency advisors are scheduled to meet on Friday to decide whether or not to approve the vaccine for emergency use.

Johnson said she expects to deliver 20 million doses by the end of March, and 100 million by summer, because the Johnson vaccine is only a single dose, and does not need to be stored in the refrigerator, it could help ramp up vaccination efforts.

The British newspaper, the Daily Mail, said, the single-dose Johnson vaccine protects against corona, according to an analysis conducted by the US Food and Drug Administration (FDA) on Wednesday.

The authority's scientists confirmed that the vaccine is 66% effective in preventing moderate to severe corona, moreover, it seems that the vaccine provides greater protection against new variants, more than was previously thought, which could help accelerate vaccination in the United States through Requesting only one dose instead of two, safe to use, as the analysis paves the way for a final decision that could come as soon as Friday, to roll out a new, easy-to-use vaccine to help tame the pandemic that has already claimed the lives of more than 500,000 Americans.

An analysis conducted by the US Food and Drug Administration found that the Johnson Johnson vaccine is safe to use and protects against corona, and because the Johnson vaccine is only one dose and does not need to be stored in the refrigerator, it may help intensify vaccination efforts, with about 1.3 million vaccines per day, and even Now, about 65 million Americans have received at least one dose of Pfizer-BioNTech, or Moderna and Moderna.

The newspaper said, the analysis is just one step in the US agency’s assessment of what will be the third vaccine option for the United States.

Armed with this advice, independent advisors to the agency will discuss whether the evidence is strong enough to recommend the long-awaited vaccine authorization, as the US Food and Drug Administration is expected to make a final decision on Friday.

Jeff Zentes, the Corona Response Coordinator at the White House, said during a briefing on Wednesday that, if authorized, between 3 and 4 million doses will be allocated next week, as a contract with the federal government guarantees 100 million doses by the end of June, explaining that the company is working on " Speed ​​up 'production.

Tucson Company Inc It is one of the best Egyptian companies specialized in the field of creating and developing Android applications and games, selling them to others, and publishing them through all the services of publishing free and paid applications and games